AAA
THRX

Affinity Asset Advisors’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Affinity Asset Advisors’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-400,726
Closed -$1.08M – 90
2023
Q3 		$1.08M Buy
400,726
+160,482
+67% +$432K 0.3% 47
2023
Q2 		$2.24M Buy
240,244
+142,023
+145% +$1.33M 0.78% 31
2023
Q1 		$872K Buy
+98,221
New +$872K 0.29% 49